erythrosine has been researched along with emtricitabine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bousquet, L; Didier, N; Farinotti, R; Mabondzo, A; Pruvost, A | 1 |
Bousquet, L; Farinotti, R; Guyot, AC; Mabondzo, A; Pruvost, A | 1 |
2 other study(ies) available for erythrosine and emtricitabine
Article | Year |
---|---|
Emtricitabine: Inhibitor and substrate of multidrug resistance associated protein.
Topics: Animals; Antineoplastic Agents, Phytogenic; Antiretroviral Therapy, Highly Active; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromatography, Liquid; Deoxycytidine; Emtricitabine; Flow Cytometry; Fluoresceins; Humans; Mass Spectrometry; Multidrug Resistance-Associated Proteins; Neutrophils; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Vincristine | 2008 |
Combination of tenofovir and emtricitabine plus efavirenz: in vitro modulation of ABC transporter and intracellular drug accumulation.
Topics: Adenine; Alkynes; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Benzoxazines; Cells, Cultured; Cyclopropanes; Deoxycytidine; Drug Interactions; Drug Therapy, Combination; Emtricitabine; Fluoresceins; Fluorescent Dyes; Humans; Leukocytes, Mononuclear; Organophosphonates; RNA, Messenger; Tenofovir; Time Factors | 2009 |